These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

30 related articles for article (PubMed ID: 11421607)

  • 1. Downregulation of miR-138 is associated with overexpression of human telomerase reverse transcriptase protein in human anaplastic thyroid carcinoma cell lines.
    Mitomo S; Maesawa C; Ogasawara S; Iwaya T; Shibazaki M; Yashima-Abo A; Kotani K; Oikawa H; Sakurai E; Izutsu N; Kato K; Komatsu H; Ikeda K; Wakabayashi G; Masuda T
    Cancer Sci; 2008 Feb; 99(2):280-6. PubMed ID: 18201269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67 Labelling Index as a Predictor of Invasive Features in Thyroid Cancer: Retrospective Analysis and Implications.
    Chowdhury R; Alsayegh R; Forest VI; Pusztaszeri MP; da Silva SD; Florianova L; Payne RJ
    Curr Oncol; 2024 Jul; 31(7):4030-4037. PubMed ID: 39057172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of antigenic constellation in human hepatocellular carcinoma.
    Ceausu M; Socea B; Serban D; Smarandache CG; Predescu D; Bacalbaşa N; Slavu I; Tulin A; Alecu L; Ceauşu Z
    Exp Ther Med; 2021 Mar; 21(3):270. PubMed ID: 33603877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear-specific accumulation of
    Hellgren LS; Olsson A; Kaufeldt A; Paulsson JO; Hysek M; Stenman A; Zedenius J; Larsson C; Höög A; Juhlin CC
    J Clin Pathol; 2021 May; 75(10):658-62. PubMed ID: 34011619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases.
    Pan DH; Wen DY; Luo YH; Chen G; Yang H; Chen JQ; He Y
    Onco Targets Ther; 2017; 10():3261-3276. PubMed ID: 28740401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase detection in the diagnosis and prognosis of cancer.
    Hiyama E; Hiyama K
    Cytotechnology; 2004 Jun; 45(1-2):61-74. PubMed ID: 19003244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma.
    Hiyama E; Yamaoka H; Matsunaga T; Hayashi Y; Ando H; Suita S; Horie H; Kaneko M; Sasaki F; Hashizume K; Nakagawara A; Ohnuma N; Yokoyama T
    Br J Cancer; 2004 Aug; 91(5):972-9. PubMed ID: 15280920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Papillary thyroid carcinoma variants.
    Lloyd RV; Buehler D; Khanafshar E
    Head Neck Pathol; 2011 Mar; 5(1):51-6. PubMed ID: 21221869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In situ detection of hTERT mRNA relates to Ki-67 labeling index in papillary thyroid carcinoma.
    Chou SJ; Chen CM; Harn HJ; Chen CJ; Liu YC
    J Surg Res; 2001 Jul; 99(1):75-83. PubMed ID: 11421607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of telomerase genes in thyroid carcinoma.
    Hoang-Vu C; Boltze C; Gimm O; Poremba C; Dockhorn-Dworniczak B; Köhrle J; Rath FW; Dralle H
    Int J Oncol; 2002 Aug; 21(2):265-72. PubMed ID: 12118320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
    Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
    Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of human telomerase reverse transcriptase mRNA in esophageal cancers and precancerous lesions.
    Amioka T; Kitadai Y; Hiyama T; Tanaka S; Yoshihara M; Haruma K; Chayama K
    Oncol Rep; 2004 Jan; 11(1):51-5. PubMed ID: 14654902
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.